midazolam has been researched along with indocyanine green in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (25.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Birnie, GG; Brodie, MJ; Cook, A; MacGilchrist, AJ; Murray, T; Scobie, G; Watkinson, G | 1 |
| Fumoto, S; Miyamoto, H; Nishida, K; Tokunaga, A | 1 |
1 review(s) available for midazolam and indocyanine green
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
3 other study(ies) available for midazolam and indocyanine green
| Article | Year |
|---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Pharmacokinetics and pharmacodynamics of intravenous midazolam in patients with severe alcoholic cirrhosis.
Topics: Adult; Antipyrine; Benzodiazepines; Endoscopy; Flicker Fusion; Half-Life; Humans; Hypnotics and Sedatives; Indocyanine Green; Kinetics; Liver Cirrhosis, Alcoholic; Midazolam; Middle Aged; Preanesthetic Medication; Reaction Time | 1986 |
Effect of Chronic Kidney Disease on Hepatic Clearance of Drugs in Rats.
Topics: Acetaminophen; Adenine; Administration, Intravenous; Animals; Cytochrome P-450 CYP3A; Disease Models, Animal; Glucuronosyltransferase; Hepatobiliary Elimination; Humans; Indocyanine Green; Kidney; Kidney Function Tests; Liver; Male; Metabolic Clearance Rate; Midazolam; Rats; Rats, Wistar; Renal Elimination; Renal Insufficiency, Chronic | 2020 |